Rohr, Jesse J. http://orcid.org/0000-0003-1184-7103
Sater, Stuart http://orcid.org/0000-0002-7434-0900
Sass, Austin M.
Marshall-Goebel, Karina http://orcid.org/0000-0002-5240-7625
Ploutz-Snyder, Robert J. http://orcid.org/0000-0002-8503-2073
Ethier, C. Ross http://orcid.org/0000-0001-6110-3052
Stenger, Michael B. http://orcid.org/0000-0003-3089-1740
Martin, Bryn A. http://orcid.org/0000-0003-1234-7880
Macias, Brandon R. http://orcid.org/0000-0003-2527-5089
Funding for this research was provided by:
Idaho Space Grant Consortium (NNX10AM75H)
National Aeronautics and Space Administration (NNX16AT06G)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R01NS11128301)
Georgia Research Alliance (N/A)
Article History
Received: 4 March 2020
Accepted: 10 September 2020
First Online: 8 October 2020
Competing interests
: B.A.M. has received grant support from Genentech, Minnetronix Neuro, Biogen, Voyager Therapeutics, and Alcyone Lifesciences. B.A.M. is a scientific advisory board member for Alcyone Lifesciences and the Chiari and Syringomyelia Foundation, and serves as a consultant to SwanBio Therapeutics, Cerebral Therapeutics, Minnetronix Neuro, and CereVasc.